North China Pharmaceutical (600812.SH): Cyclosporine soft capsules and other drugs are expected to be selected for national centralized procurement.

Zhitong Finance APP news, North China Pharmaceutical (600812.SH) announced that recently, the company and its subsidiary Hebei Huamin Pharmaceutical Co., Ltd., along with Shenzhen Huayao Southern Pharmaceutical Co., Ltd., participated in the bidding for the 12th batch of national centralized procurement organized by the National Organization for Drug Procurement Office. The company, along with Huamin and Southern, plans to have eight drugs including Cyclosporine soft capsules and Tacrolimus capsules selected in this centralized procurement. The announcement period for the proposed selection results is from July 31, 2026, to August 5, 2026.